Typical antipsychotic

Results: 308



#Item
241EU PSUR Work Sharing Summary Assessment Report Risperdal (Consta) (risperidone) BE/H/PSUR[removed]P-RMS

EU PSUR Work Sharing Summary Assessment Report Risperdal (Consta) (risperidone) BE/H/PSUR[removed]P-RMS

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2014-05-06 09:51:21
242Media Contact: Robyn Frenze[removed]office[removed]mobile)  FDA Approves Expansion of Dosing Window to Help Avoid Missed Doses in

Media Contact: Robyn Frenze[removed]office[removed]mobile) FDA Approves Expansion of Dosing Window to Help Avoid Missed Doses in

Add to Reading List

Source URL: www.janssenpharmaceuticalsinc.com

Language: English - Date: 2012-09-26 11:39:15
243Effective[removed]Xopenex HFA (levalbuterol)

Effective[removed]Xopenex HFA (levalbuterol)

Add to Reading List

Source URL: dvha.vermont.gov

Language: English - Date: 2014-06-10 14:36:26
244SEROQUEL (quetiapine fumarate) TABLETS DESCRIPTION SEROQUEL (quetiapine fumarate) is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is[removed]dibenzo [b,f

SEROQUEL (quetiapine fumarate) TABLETS DESCRIPTION SEROQUEL (quetiapine fumarate) is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is[removed]dibenzo [b,f

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 15:47:23
245Assessment:  Antipsychotics: Antipsychotics Adverse Events:

Assessment: Antipsychotics: Antipsychotics Adverse Events:

Add to Reading List

Source URL: www.ccsmh.ca

Language: English - Date: 2012-10-24 16:24:48
246Microsoft Word - nov-dec2011_12[removed]final.doc

Microsoft Word - nov-dec2011_12[removed]final.doc

Add to Reading List

Source URL: www.dhs.wisconsin.gov

Language: English - Date: 2011-12-14 16:15:33
247HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVEGA® SUSTENNA® safely and effectively. See full prescribing information for INVEGA® SUSTENNA®. INVEGA® SUSTE

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVEGA® SUSTENNA® safely and effectively. See full prescribing information for INVEGA® SUSTENNA®. INVEGA® SUSTE

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-30 17:40:12
248Chemistry / Antipsychotic / Antidepressant / Typical antipsychotic / Pharmaceutical drug / Nicotine / Anxiolytic / Atypical antipsychotic / Psychiatric medication / Pharmacology / Psychiatry / Medicine

WITS Dispensary Medication Request Date: Manufacturer:

Add to Reading List

Source URL: wits.idaho.gov

Language: English - Date: 2014-02-10 17:05:19
249Clinician Research Summary Mental Health Antipsychotics  Off-Label Use of Atypical Antipsychotics: An Update

Clinician Research Summary Mental Health Antipsychotics Off-Label Use of Atypical Antipsychotics: An Update

Add to Reading List

Source URL: effectivehealthcare.ahrq.gov

Language: English - Date: 2012-07-24 15:31:18
250IMPORTANT PRESCRIBING INFORMATION

IMPORTANT PRESCRIBING INFORMATION

Add to Reading List

Source URL: www.fda.gov

Language: English